# Output Schema Reference

## Compiled Trials DataFrame (`trials_all.csv`)

### Core Fields (Original)

| Column                      | Type     | Description                                         |
| --------------------------- | -------- | --------------------------------------------------- |
| `nct_id`                    | str      | ClinicalTrials.gov NCT identifier                   |
| `brief_title`               | str      | Brief study title                                   |
| `official_title`            | str      | Full official study title                           |
| `lead_sponsor`              | str      | Original sponsor name from API                      |
| `sponsor_normalized`        | str      | Normalized sponsor name (e.g., "Takeda")            |
| `sponsor_class`             | str      | Sponsor type: INDUSTRY, NIH, OTHER, etc.            |
| `is_industry`               | bool     | True if sponsor_class == INDUSTRY                   |
| `mechanism`                 | str      | Classified mechanism of action                      |
| `drug_names_str`            | str      | Semicolon-separated drug/intervention names (raw)   |
| `drug_names_normalized_str` | str      | Semicolon-separated canonical drug names (Phase 1B) |
| `phase_normalized`          | str      | Normalized phase label (e.g., "Phase 3")            |
| `phase_numeric`             | float    | Numeric phase for sorting (1, 1.5, 2, 2.5, 3, 4)    |
| `overall_status`            | str      | Trial status (RECRUITING, etc.)                     |
| `conditions_str`            | str      | Semicolon-separated condition names                 |
| `enrollment`                | int/null | Raw target enrollment count                         |
| `start_date`                | str      | Trial start date (YYYY-MM or YYYY-MM-DD)            |
| `start_year`                | int/null | Extracted start year                                |
| `completion_date`           | str      | Expected completion date                            |
| `study_type`                | str      | INTERVENTIONAL or OBSERVATIONAL                     |

### Enrollment Quality Fields (Phase 1A)

| Column               | Type       | Description                                            |
| -------------------- | ---------- | ------------------------------------------------------ |
| `is_pharmacological` | bool       | True if INTERVENTIONAL + classified mechanism          |
| `enrollment_clean`   | float/null | Enrollment capped at 50,000 (NaN for outliers)         |
| `enrollment_outlier` | bool       | True if enrollment > 50,000 (registries, mega-studies) |

### Geographic Fields (Phase 2A/2B)

| Column          | Type | Description                                                 |
| --------------- | ---- | ----------------------------------------------------------- |
| `countries_str` | str  | Semicolon-separated list of trial countries                 |
| `n_countries`   | int  | Number of unique countries for this trial                   |
| `regions_str`   | str  | Semicolon-separated list of regions (mapped from countries) |

### Study Design Fields (Phase 2A/2B)

| Column                  | Type | Description                                                                        |
| ----------------------- | ---- | ---------------------------------------------------------------------------------- |
| `allocation`            | str  | Randomization type: RANDOMIZED, NON_RANDOMIZED, etc.                               |
| `masking`               | str  | Blinding level: DOUBLE, SINGLE, NONE, QUADRUPLE, etc.                              |
| `intervention_model`    | str  | Study model: PARALLEL, CROSSOVER, SINGLE_GROUP, etc.                               |
| `study_design_category` | str  | Derived: "RCT Double-Blind", "RCT Open-Label", "Single-Arm", "Observational", etc. |

### Arms & Comparator Fields (Phase 2A/2B)

| Column                  | Type | Description                                                      |
| ----------------------- | ---- | ---------------------------------------------------------------- |
| `has_placebo_arm`       | bool | True if trial has a placebo comparator arm                       |
| `has_active_comparator` | bool | True if trial has an active comparator arm                       |
| `is_head_to_head`       | bool | True if trial is head-to-head (active comparator + experimental) |
| `n_arms`                | int  | Number of arms in the trial                                      |
| `is_combination`        | bool | True if trial has 2+ active drug interventions                   |

### Endpoint Fields (Phase 2A/2B)

| Column               | Type | Description                     |
| -------------------- | ---- | ------------------------------- |
| `primary_endpoint`   | str  | First primary outcome measure   |
| `endpoint_timeframe` | str  | First primary outcome timeframe |

### Eligibility Fields (Phase 2A/2B)

| Column          | Type       | Description                           |
| --------------- | ---------- | ------------------------------------- |
| `min_age`       | str        | Minimum age string (e.g., "18 Years") |
| `max_age`       | str        | Maximum age string (e.g., "80 Years") |
| `min_age_years` | float/null | Minimum age in years (numeric)        |
| `max_age_years` | float/null | Maximum age in years (numeric)        |
| `sex`           | str        | Sex eligibility: ALL, MALE, FEMALE    |
| `is_pediatric`  | bool       | True if min or max age < 18 years     |

### Regulatory Fields (Phase 2A/2B)

| Column                  | Type      | Description                                      |
| ----------------------- | --------- | ------------------------------------------------ |
| `is_fda_regulated_drug` | bool/null | True if FDA-regulated drug                       |
| `has_dmc`               | bool/null | True if Data Safety Monitoring Committee present |

### Collaborator Fields (Phase 2A/2B)

| Column              | Type | Description                                         |
| ------------------- | ---- | --------------------------------------------------- |
| `collaborators_str` | str  | Semicolon-separated collaborating institution names |

### Classification Fields (Phase 4B)

| Column          | Type | Description                                 |
| --------------- | ---- | ------------------------------------------- |
| `is_biosimilar` | bool | True if trial involves a biosimilar product |

---

## Mechanism x Phase Matrix (`trials_by_mechanism.csv`)

Cross-tabulation with mechanisms as rows, phases as columns, and trial counts as
values. Includes a "Total" column.

## Sponsor Summary (`trials_by_sponsor.csv`)

| Column               | Type | Description                    |
| -------------------- | ---- | ------------------------------ |
| `sponsor_normalized` | str  | Index: normalized sponsor name |
| `trials`             | int  | Total number of trials         |
| `mechanisms`         | int  | Number of distinct mechanisms  |
| `industry`           | bool | Industry-sponsored             |

## Reports

### `landscape_report.pdf`

Publication-quality PDF report generated by reportlab. Contains 24 sections:

- Title page with executive summary stats (trial count, mechanisms, sponsors)
- Full 6-panel landscape visualization (embedded from PNG)
- Mechanism × Phase distribution table
- Indication breakdown (config-driven categories)
- Mechanism deep-dives with drug pipeline tables
- Late-stage pipeline (Phase 3) analysis
- Upcoming readouts section with time-to-readout estimates
- Config-driven mechanism highlight sections (e.g., Anti-IL-23 Focus, Anti-TL1A)
- Sponsor competitive landscape table (top 20 sponsors)
- Company portfolio analysis
- Industry vs Academic breakdown
- Config-driven sponsor highlight sections (e.g., Takeda Portfolio)
- Enrollment & investment signals (using clean enrollment)
- Geographic landscape (top countries, region breakdown)
- Study design analysis (RCT rates, double-blind by phase)
- Phase transition funnel
- Phase 3 endpoint comparison
- Combination therapy landscape
- Patient population analysis (pediatric vs adult)
- Trial arms & comparator analysis (placebo, H2H)
- Biosimilar landscape
- Whitespace & unmet needs
- Regulatory signals (FDA, DSMB rates)
- Data notes with query parameters and caveats

### `landscape_report.md`

Markdown version with the same 24 sections. Useful for embedding in other
documents or rendering in Biomni.

### `landscape_supplementary.png`

4-panel supplementary visualization:

1. Top 15 countries by trial presence (horizontal bar)
2. Study design by phase (stacked bar)
3. Enrollment distribution by mechanism (box plot, log scale)
4. Phase transition funnel (grouped bar)

## Analysis Object (`analysis_object.pkl`)

Python dict with keys:

| Key                      | Type      | Description                                      |
| ------------------------ | --------- | ------------------------------------------------ |
| `trials_df`              | DataFrame | Full compiled trials DataFrame (46+ columns)     |
| `parameters`             | dict      | Query parameters used                            |
| `n_total`                | int       | Total trial count                                |
| `n_by_mechanism`         | dict      | Trial counts per mechanism                       |
| `n_by_phase`             | dict      | Trial counts per phase                           |
| `n_by_sponsor`           | dict      | Trial counts per sponsor                         |
| `n_industry`             | int       | Industry-sponsored trial count                   |
| `unique_mechanisms`      | int       | Number of distinct mechanisms                    |
| `unique_sponsors`        | int       | Number of distinct sponsors                      |
| `mechanism_phase_matrix` | dict      | Nested dict of mechanism x phase counts          |
| `timestamp`              | str       | ISO timestamp of export                          |
| `n_with_geographic_data` | int       | Trials with location data (Phase 2)              |
| `n_by_design`            | dict      | Trial counts per study design category (Phase 2) |
| `n_combination`          | int       | Combination therapy trials (Phase 2)             |
| `n_pediatric`            | int       | Pediatric trials (Phase 2)                       |
| `n_biosimilar`           | int       | Biosimilar trials (Phase 4B)                     |
| `enrollment_outliers`    | int       | Enrollment outlier count (Phase 1A)              |
